Ribociclib for HR+ Breast Cancer: Benefits, Side Effects & Comparison
Ribociclib is a CDK4/6 inhibitor that improves survival in hormone receptor‑positive breast cancer. Learn how it works, dosing, side effects, and how it compares to similar drugs.
Read More